Publications by authors named "Ryosuke Ide"

Claim this Profile
A
Assessment of Potential Drug-Drug Interactions for Novel Oral Melanocortin-1 Receptor Agonist Dersimelagon.
Akihito Ogasawara, Ryosuke Ide, Shinsuke Inoue, Minoru Tsuda, Renli Teng

Pharmacol Res Perspect· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Hepatic and Renal Impairment on the Pharmacokinetics of Dersimelagon (MT-7117), an Oral Melanocortin-1 Receptor Agonist.
Akihito Ogasawara, Ryosuke Ide, Shinsuke Inoue, Renli Teng, Atsuhiro Kawaguchi

Clin Pharmacol Drug Dev· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results from a first-in-human study of dersimelagon, an investigational oral selective MC1R agonist.
Akihito Ogasawara, Kei Ogawa, Ryosuke Ide, Yuka Ikenaga, Chie Fukunaga

Eur J Clin Pharmacol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Oral Bioavailability and Effect of Various Gastric Conditions on the Pharmacokinetics of Dersimelagon in Healthy Adult Volunteers.
Kei Ogawa, Ryosuke Ide, Kirstine Belongie, Minoru Tsuda, Hiroki Kawanishi

Clin Pharmacol Drug Dev· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distribution Behavior of Single-Stranded DNA Molecules in an Amino-Group-Functionalized Silica Microparticle.
Akihisa Miyagawa, Ryosuke Ide, Shigenori Nagatomo, Kiyoharu Nakatani

Langmuir· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and functional characterization of novel nonsynonymous variants in the human multidrug and toxin extrusion 2-K.
Kenta Nishimura, Ryosuke Ide, Takeshi Hirota, Kana Kawazu, Sho Kodama

Drug Metab Dispos· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis